Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models

Javier Rueda-Carrasco1, Dimitra Sokolova1,2, Sang-Eun Lee1,3

  • 1UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.

The EMBO Journal
|August 14, 2023
PubMed

Insights

Microglia engulf hyperactive synapses in early Alzheimer's disease (AD). This process, mediated by phosphatidylserine (ePtdSer) and TREM2, helps reduce synaptic hyperactivity, suggesting a protective role for microglia in AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Neuronal hyperactivity characterizes early Alzheimer's disease (AD).
  • Microglia are implicated in AD pathogenesis, but mechanisms linking them to synaptic hyperactivity are unclear.
  • Understanding microglia-synapse interactions is crucial for early AD intervention.

Purpose of the Study:

  • To investigate the molecular mechanisms of microglia-synapse engulfment in AD.
  • To determine the role of phosphatidylserine (ePtdSer) and TREM2 in this process.
  • To assess the therapeutic potential of targeting microglia-synapse interactions in AD.

Main Methods:

  • Super-resolution microscopy and 3D live imaging of co-cultures.
  • In vivo lipid imaging in genetic models of AD.
  • Analysis of TREM2 loss-of-function variants in mice and humans.

Main Results:

  • Amyloid-beta (Aβ) oligomers induce synaptic hyperactivity and phosphatidylserine externalization (ePtdSer).
  • Microglia engulf these "eat-me" signal-displaying spines via TREM2, reducing hyperactivity.
  • Impaired ePtdSer-TREM2 signaling and increased apoptotic-like synapses observed in TREM2 variants.

Conclusions:

  • Microglia actively remove hyperactive, ePtdSer-positive synapses in an Aβ-dependent manner.
  • The ePtdSer-TREM2 pathway is critical for microglia-mediated synapse pruning in AD.
  • Microglia may exert a beneficial role in early AD by clearing dysfunctional synapses.